Medication info
Rabeprazole Sodium 10 mg Tablet

Rabeprazole Sodium 10 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Albozen Korea Co., Ltd.
Appearance
Yellowish round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x2)
Approval status
Active

MFDS item code 201400372 · Approved 2014.01.28 · Insurance code 652603970

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of 10 mg or 20 mg orally twice daily may be administered. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Use with caution, as hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Albozen Korea Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medicine is effective in treating gastric ulcers and duodenal ulcers and helps relieve the symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also used for long-term maintenance therapy for gastroesophageal reflux disease. In patients with gastrointestinal ulcers infected with Helicobacter pylori, it is administered in combination with antibiotics for treatment. It is applied to treat Zollinger-Ellison syndrome by controlling excessive gastric acid secretion. It is used for the treatment of various gastrointestinal-related diseases and symptom improvement.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of 10 mg or 20 mg orally twice daily may be administered. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Use with caution, as hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This drug should not be used in patients with a history of allergic reactions or hypersensitivity to specific components. It is safer for pregnant or breastfeeding women not to take this medication. Patients with impaired liver function or elderly individuals should exercise more caution when using this drug. If allergic symptoms such as skin rash, itching, or hives appear during treatment, use should be discontinued immediately. It is essential to check for adverse reactions through regular blood tests and liver function tests. This medication can cause various gastrointestinal symptoms, such as diarrhea, abdominal pain, or nausea, so if symptoms worsen, consult a physician. Mental symptoms may include headaches, insomnia, and dizziness, so caution is advised. This drug may interact with specific antibiotics or other medications, so it is crucial to inform your doctor or pharmacist about any other medications you are taking. Long-term use may increase the risk of bone fractures, so if necessary, it is advisable to undergo a bone density test as directed by your doctor. This medication reduces gastric acid secretion, which may increase the risk of bacterial infections in the gastrointestinal tract; therefore, notify healthcare professionals if diarrhea persists. Drowsiness or dizziness may occur, so be careful when driving or operating machinery. Do not chew or crush this tablet; it should be swallowed whole as a tablet. Keep out of reach of children and do not transfer to other containers for safety.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, purpura, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, neuroexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased circulating blood volume, limb atony, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, hypertonia, neuralgia, singleton contractions, sweating, alopecia, xerosis, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal visual fields, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, ocular pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, urinary difficulty, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyrotropin, chest pain, chills, fever, urinary tract infection, erythema, malaise, weight gain, visual disturbances, anorexia, cervical stiffness, photosensitivity reactions, hangover effects, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, arthralgia, renal interstitial nephritis, gynecomastia, elevated thyrotropin, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellowish round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.